# CareDx, Inc.: Form 10-Q for the period ended Sep 30, 2015

- Company: [CareDx, Inc.](/companies/cdna.md) (CIK 1217234)
- Form: 10-Q
- Filed: 2015-11-13
- Accepted by EDGAR: Nov 13, 2015, 21:43 ET
- Period: 2015-09-30
- Accession: 0001193125-15-377139
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1217234/000119312515377139/d63461d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1217234/000119312515377139/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-07-01 to 2015-09-30 | $7.2m | us-gaap:Revenues |
| Revenue | 9 months, 2015-01-01 to 2015-09-30 | $21.5m | us-gaap:Revenues |
| Research and development | 3 months, 2015-07-01 to 2015-09-30 | $2.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2015-01-01 to 2015-09-30 | $6.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2015-07-01 to 2015-09-30 | −$3.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2015-01-01 to 2015-09-30 | −$7.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2015-07-01 to 2015-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2015-01-01 to 2015-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-07-01 to 2015-09-30 | −$3.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2015-01-01 to 2015-09-30 | −$8.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-07-01 to 2015-09-30 | −$0.29 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2015-01-01 to 2015-09-30 | −$0.76 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-07-01 to 2015-09-30 | −$0.29 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2015-01-01 to 2015-09-30 | −$0.76 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-07-01 to 2015-09-30 | 11,890,057 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2015-01-01 to 2015-09-30 | 11,846,921 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2015-01-01 to 2015-09-30 | −$5.8m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2015-01-01 to 2015-09-30 | $1.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2015-09-30 | $34.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-09-30 | $38.0m | us-gaap:AssetsCurrent |
| Total assets | at 2015-09-30 | $59.3m | us-gaap:Assets |
| Current liabilities | at 2015-09-30 | $10.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-09-30 | $25.4m | us-gaap:Liabilities |
| Long-term debt | at 2015-09-30 | $12.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2015-09-30 | $3.6m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2015-09-30 | $33.9m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1217234/000119312515377139/d63461d10q.htm

Filed Nov 13, 2015.
Source: SEC EDGAR, the filing index for accession 0001193125-15-377139. Last ingested by Listed: Nov 13, 2026, 16:18 ET. No prices; not investment advice.
